Siegfried: Management Changes

21-Mar-2017 - Switzerland

Revolutionize your production: real-time Raman analysis for maximum efficiency

Efficient inline analysis for liquids and solids

User-friendly software for effortless Design of Experiments (DoE)

Siegfried Group (Zofingen) has announced two management changes. Chief Financial Officer (CFO) Michael Hüsler will be leaving the company at the end of April 2017 to take up a new professional challenge. Michael Hüsler has been CFO and a member of the firm’s Executive Committee since 2009. The Board of Directors has appointed Dr. Reto Suter, formerly CFO and Chief Investment Officer at Lonrho, as his successor. Reto Suter will take over the reins on May 1, 2017.

Says CEO Dr. Rudolf Hanko: “Michael Hüsler led the Finance department successfully and was instrumental in shaping and supporting our company’s expansion. He made a major personal contribution to Siegfried’s overall success during his tenure. We have found a highly experienced and competent successor to Michael Hüsler in Dr. Reto Suter.”

Likewise with effect from May 1, 2017, the Board of Directors has entrusted Dr. Wolfgang Wienand with the management of the Siegfried Group’s global research and development activities. He will be taking over these duties from Dr. René Imwinkelried and will perform this function in addition to his existing responsibilities as Head Strategy, M&A, Legal, IP and Regulatory Affairs. René Imwinkelried continues to manage the Global Technical Operations department – a role he has held since the beginning of the year.

As per May 1, 2017, the members of the Executive Committee are as follows:

Dr. Rudolf Hanko, CEO
Dr. Wolfgang Wienand, Head of Research and Development,
Head Strategy and M&A, Legal, IP, Regulatory Affairs
Dr. René Imwinkelried, Head of Global Operations
Dr. Reto Suter, CFO
Marianne Späne, Head Business Development & Sales
Arnoud Middel, Head Human Re

https://www.bionity.com/en/news/162459/siegfried-management-changes.html